CRVS Operating Income - Corvus Pharmaceuticals, Inc.

Complete source-backed operating income history.

Available history: 2014-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Operating Income

Date	Operating Income
2026-06-30	-$19.3M
2026-03-31	-$14.88M
2025-12-31	-$12.22M
2025-09-30	-$10.57M
2025-06-30	-$10.26M
2025-03-31	-$9.92M
2024-12-31	-$8.11M
2024-09-30	-$7.26M
2024-06-30	-$5.94M
2024-03-31	-$6.25M
2023-12-31	-$5.65M
2023-09-30	-$5.56M
2023-06-30	-$5.62M
2023-03-31	-$6.57M
2022-12-31	-$5.67M
2022-09-30	-$12.47M
2022-06-30	-$7.01M
2022-03-31	-$7.41M
2021-12-31	-$6.81M
2021-09-30	-$9.05M
2021-06-30	-$11.29M
2021-03-31	-$11.48M
2020-12-31	-$9.88M
2020-09-30	-$9.85M
2020-06-30	-$10.77M
2020-03-31	-$13.27M
2019-12-31	-$11.44M
2019-09-30	-$11.51M
2019-06-30	-$13.6M
2019-03-31	-$12.31M
2018-12-31	-$11.17M
2018-09-30	-$11.15M
2018-06-30	-$12.26M
2018-03-31	-$14.64M
2017-12-31	-$12.19M
2017-09-30	-$12.94M
2017-06-30	-$15.17M
2017-03-31	-$16.22M
2016-12-31	-$11.25M
2016-09-30	-$10.48M
2016-06-30	-$8.83M
2016-03-31	-$6.43M
2015-12-31	-$6.1M
2015-09-30	-$3.12M
2015-06-30	-$2.33M
2015-03-31	-$2.21M

Annual Operating Income

Date	Operating Income
2025-12-31	-$42.97M
2024-12-31	-$27.55M
2023-12-31	-$23.41M
2022-12-31	-$32.57M
2021-12-31	-$38.63M
2020-12-31	-$43.76M
2019-12-31	-$48.85M
2018-12-31	-$49.22M
2017-12-31	-$56.52M
2016-12-31	-$36.98M
2015-12-31	-$13.77M
2014-12-31	-$161,000.00